ResMed's largely in-line third quarter results showcased a rising gross margin, while management also moved to ease market ...

Noise level: Our pick for the best quiet CPAP machine is the Luna G3, but you'll want to make sure that whichever model you ...

Resmed says that U.S. Customs and Border Protection has confirmed that its devices will continue to be exempt from tariffs ...

Australian sleep health giant Resmed has locked down an exemption from Donald Trump’s sweeping trade tariffs. Resmed produces ...

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the third quarter of fiscal 2025 were $2.37, up 11.3% year over year.

Analysts have provided ResMed with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price ...

ResMed dominates healthcare devices with innovation, recurring revenues, and market leadership. See why we believe RMD stock ...

Piper Sandler lowered the firm’s price target on ResMed (RMD) to $248 from $260 and keeps a Neutral rating on the shares. The firm notes the ...

In the assessment of 12-month price targets, analysts unveil insights for ResMed, presenting an average target of $267.0, a ...

Higher adherence supports both reimbursement rates from payers and the resupply of masks and accessories. ResMed also plays a key role in producing clinical data that demonstrates treatment can ...